Bicycle Therapeutics (BCYC) Operating Leases (2019 - 2025)
Historic Operating Leases for Bicycle Therapeutics (BCYC) over the last 7 years, with Q3 2025 value amounting to $981000.0.
- Bicycle Therapeutics' Operating Leases fell 8227.0% to $981000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $981000.0, marking a year-over-year decrease of 8227.0%. This contributed to the annual value of $4.0 million for FY2024, which is 5747.18% down from last year.
- As of Q3 2025, Bicycle Therapeutics' Operating Leases stood at $981000.0, which was down 8227.0% from $1.8 million recorded in Q2 2025.
- Over the past 5 years, Bicycle Therapeutics' Operating Leases peaked at $14.4 million during Q1 2023, and registered a low of $981000.0 during Q3 2025.
- In the last 5 years, Bicycle Therapeutics' Operating Leases had a median value of $8.0 million in 2024 and averaged $7.6 million.
- As far as peak fluctuations go, Bicycle Therapeutics' Operating Leases surged by 273591.55% in 2021, and later crashed by 8227.0% in 2025.
- Bicycle Therapeutics' Operating Leases (Quarter) stood at $12.1 million in 2021, then dropped by 9.9% to $10.9 million in 2022, then dropped by 13.81% to $9.4 million in 2023, then tumbled by 57.47% to $4.0 million in 2024, then plummeted by 75.41% to $981000.0 in 2025.
- Its Operating Leases stands at $981000.0 for Q3 2025, versus $1.8 million for Q2 2025 and $2.6 million for Q1 2025.